

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.87125825 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.79845706 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.78555840 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.71821755 |
| 5 | regulation of synapse structural plasticity (GO:0051823) | 5.20677032 |
| 6 | vocalization behavior (GO:0071625) | 5.12577732 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.01656980 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.98821173 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.89308089 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.86892943 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.79660559 |
| 12 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.78079539 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.77349657 |
| 14 | glutamate secretion (GO:0014047) | 4.72377717 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.68606299 |
| 16 | cerebellar granule cell differentiation (GO:0021707) | 4.66562654 |
| 17 | amino acid import (GO:0043090) | 4.63219727 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51722396 |
| 19 | prepulse inhibition (GO:0060134) | 4.46125236 |
| 20 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.37848249 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.28683165 |
| 22 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.28260645 |
| 23 | protein localization to synapse (GO:0035418) | 4.20211195 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.18261756 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.14668264 |
| 26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.13441464 |
| 27 | exploration behavior (GO:0035640) | 4.10445205 |
| 28 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.07829467 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 4.07433035 |
| 30 | auditory behavior (GO:0031223) | 4.05709150 |
| 31 | neuronal action potential propagation (GO:0019227) | 4.01798554 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 4.00649919 |
| 33 | dendritic spine morphogenesis (GO:0060997) | 4.00447080 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.96969671 |
| 35 | synaptic transmission, dopaminergic (GO:0001963) | 3.95307209 |
| 36 | regulation of ARF protein signal transduction (GO:0032012) | 3.95109877 |
| 37 | potassium ion homeostasis (GO:0055075) | 3.91648151 |
| 38 | synaptic vesicle endocytosis (GO:0048488) | 3.91171134 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.88753210 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 3.85378940 |
| 41 | neuromuscular process controlling balance (GO:0050885) | 3.83200984 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 3.81815508 |
| 43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.81559310 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.80631461 |
| 45 | long-term memory (GO:0007616) | 3.79092693 |
| 46 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.77496994 |
| 47 | positive regulation of neurotransmitter transport (GO:0051590) | 3.75290782 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74220154 |
| 49 | behavioral response to cocaine (GO:0048148) | 3.71969462 |
| 50 | regulation of synapse maturation (GO:0090128) | 3.71494469 |
| 51 | response to auditory stimulus (GO:0010996) | 3.71034591 |
| 52 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.69842660 |
| 53 | axon ensheathment in central nervous system (GO:0032291) | 3.68514761 |
| 54 | central nervous system myelination (GO:0022010) | 3.68514761 |
| 55 | striatum development (GO:0021756) | 3.68202158 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.68062910 |
| 57 | glutamate receptor signaling pathway (GO:0007215) | 3.65329860 |
| 58 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.64690455 |
| 59 | cellular sodium ion homeostasis (GO:0006883) | 3.64576007 |
| 60 | potassium ion import (GO:0010107) | 3.62958399 |
| 61 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.62030582 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.61834841 |
| 63 | regulation of female receptivity (GO:0045924) | 3.61472026 |
| 64 | adenosine receptor signaling pathway (GO:0001973) | 3.59582433 |
| 65 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.59578987 |
| 66 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.59451129 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53625672 |
| 68 | * regulation of dendritic spine morphogenesis (GO:0061001) | 3.53511674 |
| 69 | activation of protein kinase A activity (GO:0034199) | 3.53188909 |
| 70 | cell communication by electrical coupling (GO:0010644) | 3.52536686 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 3.49720249 |
| 72 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.49081268 |
| 73 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.47636145 |
| 74 | transmission of nerve impulse (GO:0019226) | 3.43768146 |
| 75 | response to amphetamine (GO:0001975) | 3.42571924 |
| 76 | postsynaptic membrane organization (GO:0001941) | 3.39831168 |
| 77 | regulation of glutamate secretion (GO:0014048) | 3.38437297 |
| 78 | long-term synaptic potentiation (GO:0060291) | 3.36797180 |
| 79 | acidic amino acid transport (GO:0015800) | 3.35468983 |
| 80 | dopamine receptor signaling pathway (GO:0007212) | 3.34360175 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.31656582 |
| 82 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.30459107 |
| 83 | vesicle docking involved in exocytosis (GO:0006904) | 3.30082063 |
| 84 | neurotransmitter transport (GO:0006836) | 3.29602555 |
| 85 | proline transport (GO:0015824) | 3.29442334 |
| 86 | neuron cell-cell adhesion (GO:0007158) | 3.28949423 |
| 87 | glycine transport (GO:0015816) | 3.27278863 |
| 88 | regulation of neurotransmitter levels (GO:0001505) | 3.26897122 |
| 89 | response to histamine (GO:0034776) | 3.25530806 |
| 90 | female mating behavior (GO:0060180) | 3.24008129 |
| 91 | sodium ion export (GO:0071436) | 3.22452884 |
| 92 | dicarboxylic acid transport (GO:0006835) | 3.22057994 |
| 93 | neuronal ion channel clustering (GO:0045161) | 3.21743923 |
| 94 | behavioral fear response (GO:0001662) | 3.14178697 |
| 95 | behavioral defense response (GO:0002209) | 3.14178697 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.09300044 |
| 97 | positive regulation of dendritic spine development (GO:0060999) | 3.08834959 |
| 98 | regulation of neurotransmitter secretion (GO:0046928) | 3.08243623 |
| 99 | cAMP catabolic process (GO:0006198) | 3.08048663 |
| 100 | visual learning (GO:0008542) | 3.06236206 |
| 101 | chemosensory behavior (GO:0007635) | 3.06046683 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 3.05211192 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 3.05010877 |
| 104 | membrane hyperpolarization (GO:0060081) | 3.04867555 |
| 105 | neuromuscular process controlling posture (GO:0050884) | 3.04097850 |
| 106 | mating behavior (GO:0007617) | 3.03912757 |
| 107 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.03296668 |
| 108 | positive regulation of synapse maturation (GO:0090129) | 3.02843330 |
| 109 | vesicle docking (GO:0048278) | 3.01802065 |
| 110 | positive regulation of dendrite development (GO:1900006) | 3.01740532 |
| 111 | regulation of exocytosis (GO:0017157) | 3.01468022 |
| 112 | synaptic vesicle transport (GO:0048489) | 3.01207970 |
| 113 | establishment of synaptic vesicle localization (GO:0097480) | 3.01207970 |
| 114 | cell communication involved in cardiac conduction (GO:0086065) | 3.01022497 |
| 115 | synaptic transmission (GO:0007268) | 2.99548300 |
| 116 | acid secretion (GO:0046717) | 2.99517284 |
| 117 | membrane depolarization during action potential (GO:0086010) | 2.99207981 |
| 118 | mechanosensory behavior (GO:0007638) | 2.97919101 |
| 119 | serotonin metabolic process (GO:0042428) | 2.97377669 |
| 120 | L-glutamate transport (GO:0015813) | 2.97268389 |
| 121 | learning (GO:0007612) | 2.96718391 |
| 122 | cerebellar Purkinje cell layer development (GO:0021680) | 2.95473363 |
| 123 | dendritic spine organization (GO:0097061) | 2.95190876 |
| 124 | * regulation of dendritic spine development (GO:0060998) | 2.94899319 |
| 125 | neuromuscular process (GO:0050905) | 2.94861367 |
| 126 | response to gravity (GO:0009629) | 2.93678962 |
| 127 | regulation of neurotransmitter uptake (GO:0051580) | 2.91889403 |
| 128 | membrane depolarization (GO:0051899) | 2.91799389 |
| 129 | regulation of vesicle fusion (GO:0031338) | 2.91577889 |
| 130 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.91480959 |
| 131 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.91480959 |
| 132 | visual behavior (GO:0007632) | 2.90310219 |
| 133 | negative regulation of amino acid transport (GO:0051956) | 2.87847303 |
| 134 | alanine transport (GO:0032328) | 2.87535402 |
| 135 | regulation of synaptic transmission (GO:0050804) | 2.85233054 |
| 136 | fear response (GO:0042596) | 2.84529597 |
| 137 | L-amino acid import (GO:0043092) | 2.82443713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.03031515 |
| 2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.41505679 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02333176 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98169535 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.85363180 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84688568 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69127795 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.68131271 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65741847 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65741847 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65103771 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61177693 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56366126 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55089097 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53099248 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41396673 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37455077 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28238007 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27784378 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22302114 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.21110397 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19858775 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11672597 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10874416 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06808794 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97290005 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95810244 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83068617 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80970594 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71806382 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62145885 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58478270 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56660123 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51328258 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42599445 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40507224 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38160819 |
| 38 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.37923551 |
| 39 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36475378 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36169183 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.35460082 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32503992 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32425183 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31515113 |
| 45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30251967 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30143460 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29866761 |
| 48 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26548575 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26268242 |
| 50 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25052682 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24499015 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23434360 |
| 53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21901946 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21442515 |
| 55 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20808801 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19813256 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19469192 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.17601875 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17332770 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17207403 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14909926 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13549274 |
| 63 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12651244 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12313057 |
| 65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11968061 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11832273 |
| 67 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.10586827 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10564163 |
| 69 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08054901 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07495886 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06457245 |
| 72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06304934 |
| 73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05898340 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03932978 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03263335 |
| 76 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02068762 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02036154 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01540078 |
| 79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00936754 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.00698225 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00193846 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99323167 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99063192 |
| 84 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98754866 |
| 85 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97316358 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97126701 |
| 87 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97023554 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96579899 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96256884 |
| 90 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95619507 |
| 91 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95067787 |
| 92 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94195699 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94167372 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92405232 |
| 95 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91297490 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90970572 |
| 97 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.90967129 |
| 98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90329427 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90227015 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89854540 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89829567 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89511404 |
| 103 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.89400801 |
| 104 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89190400 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89189080 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88431245 |
| 107 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87136693 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86987182 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86905045 |
| 110 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86741454 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86706844 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85639164 |
| 113 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85322659 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84617301 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84614983 |
| 116 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.83957605 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83093146 |
| 118 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82205189 |
| 119 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.82110323 |
| 120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.82087680 |
| 121 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81948940 |
| 122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.81153404 |
| 123 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81045566 |
| 124 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80102010 |
| 125 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.79998567 |
| 126 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.79881264 |
| 127 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79228893 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.78899231 |
| 129 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78870085 |
| 130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.78861988 |
| 131 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78607276 |
| 132 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.77778762 |
| 133 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77449797 |
| 134 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77243738 |
| 135 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.77065973 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76950959 |
| 137 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.76079397 |
| 138 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.75905077 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75752262 |
| 140 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74195038 |
| 141 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.73626332 |
| 142 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.73003283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.81643628 |
| 2 | MP0002822_catalepsy | 6.47254836 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.17750452 |
| 4 | MP0003880_abnormal_central_pattern | 4.12362002 |
| 5 | MP0009745_abnormal_behavioral_response | 3.60130956 |
| 6 | MP0004270_analgesia | 3.51939222 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.46769900 |
| 8 | MP0002064_seizures | 3.08960873 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.78696757 |
| 10 | MP0009046_muscle_twitch | 2.76011263 |
| 11 | MP0001486_abnormal_startle_reflex | 2.74447659 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.54713434 |
| 13 | MP0002272_abnormal_nervous_system | 2.35539671 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.34801538 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.20766815 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.19637076 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.19318421 |
| 18 | MP0005646_abnormal_pituitary_gland | 2.14155613 |
| 19 | MP0003329_amyloid_beta_deposits | 2.10687118 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.06135621 |
| 21 | MP0002736_abnormal_nociception_after | 1.84954535 |
| 22 | MP0003123_paternal_imprinting | 1.83606006 |
| 23 | MP0001529_abnormal_vocalization | 1.81831235 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.80739529 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.76557516 |
| 26 | MP0005386_behavior/neurological_phenoty | 1.73891928 |
| 27 | MP0004924_abnormal_behavior | 1.73891928 |
| 28 | MP0003075_altered_response_to | 1.72394049 |
| 29 | MP0008569_lethality_at_weaning | 1.72325752 |
| 30 | MP0001970_abnormal_pain_threshold | 1.71088517 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.63064873 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.61561451 |
| 33 | MP0003879_abnormal_hair_cell | 1.60420987 |
| 34 | MP0001984_abnormal_olfaction | 1.57367468 |
| 35 | MP0004858_abnormal_nervous_system | 1.50910279 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.49225138 |
| 37 | MP0003633_abnormal_nervous_system | 1.44636749 |
| 38 | MP0004885_abnormal_endolymph | 1.43286272 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.36517458 |
| 40 | MP0003690_abnormal_glial_cell | 1.35262466 |
| 41 | MP0008872_abnormal_physiological_respon | 1.34756588 |
| 42 | MP0008874_decreased_physiological_sensi | 1.34084204 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.32874316 |
| 44 | MP0003122_maternal_imprinting | 1.28830403 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.28789492 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.25108308 |
| 47 | MP0000955_abnormal_spinal_cord | 1.24050951 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.21300822 |
| 49 | MP0001177_atelectasis | 1.20244265 |
| 50 | MP0000604_amyloidosis | 1.19630191 |
| 51 | MP0003631_nervous_system_phenotype | 1.16123818 |
| 52 | MP0002184_abnormal_innervation | 1.15213640 |
| 53 | MP0005360_urolithiasis | 1.14649729 |
| 54 | MP0000778_abnormal_nervous_system | 1.13377310 |
| 55 | MP0001346_abnormal_lacrimal_gland | 1.13005906 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.11101219 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.10728585 |
| 58 | MP0001905_abnormal_dopamine_level | 1.10697961 |
| 59 | * MP0002882_abnormal_neuron_morphology | 1.09978780 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.09611371 |
| 61 | MP0005535_abnormal_body_temperature | 1.08165140 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.04254457 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 1.02804648 |
| 64 | MP0002090_abnormal_vision | 1.02569140 |
| 65 | MP0004742_abnormal_vestibular_system | 1.02347850 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.01392921 |
| 67 | MP0004147_increased_porphyrin_level | 0.95848121 |
| 68 | MP0000013_abnormal_adipose_tissue | 0.95369194 |
| 69 | MP0004142_abnormal_muscle_tone | 0.88898959 |
| 70 | MP0003283_abnormal_digestive_organ | 0.88290728 |
| 71 | MP0002152_abnormal_brain_morphology | 0.88263352 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87840352 |
| 73 | MP0005365_abnormal_bile_salt | 0.85664507 |
| 74 | MP0010329_abnormal_lipoprotein_level | 0.85626002 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.85579932 |
| 76 | MP0004085_abnormal_heartbeat | 0.84015670 |
| 77 | MP0005409_darkened_coat_color | 0.83313613 |
| 78 | MP0000751_myopathy | 0.82850977 |
| 79 | MP0005166_decreased_susceptibility_to | 0.81459607 |
| 80 | MP0001188_hyperpigmentation | 0.77735380 |
| 81 | MP0000920_abnormal_myelination | 0.76642661 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 0.75521132 |
| 83 | MP0000579_abnormal_nail_morphology | 0.75329410 |
| 84 | MP0002229_neurodegeneration | 0.75087966 |
| 85 | MP0000566_synostosis | 0.74204346 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.73979506 |
| 87 | MP0003632_abnormal_nervous_system | 0.73969006 |
| 88 | MP0004043_abnormal_pH_regulation | 0.72090218 |
| 89 | MP0003787_abnormal_imprinting | 0.70871400 |
| 90 | MP0003634_abnormal_glial_cell | 0.68499041 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.67612955 |
| 92 | MP0001664_abnormal_digestion | 0.64204510 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.64110034 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.63830255 |
| 95 | MP0000569_abnormal_digit_pigmentation | 0.63557459 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62228299 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.60966012 |
| 98 | MP0004130_abnormal_muscle_cell | 0.58504158 |
| 99 | MP0005332_abnormal_amino_acid | 0.55225161 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.54958303 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.54844698 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.54003339 |
| 103 | MP0010769_abnormal_survival | 0.51269871 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.50911749 |
| 105 | MP0005499_abnormal_olfactory_system | 0.50304416 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.50304416 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.49111126 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.48894573 |
| 109 | MP0004510_myositis | 0.48475260 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.48327099 |
| 111 | MP0005448_abnormal_energy_balance | 0.48029428 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.48017421 |
| 113 | MP0001943_abnormal_respiration | 0.47915660 |
| 114 | MP0010768_mortality/aging | 0.47379070 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.46804372 |
| 116 | MP0010770_preweaning_lethality | 0.46600963 |
| 117 | MP0002082_postnatal_lethality | 0.46600963 |
| 118 | MP0003956_abnormal_body_size | 0.45165659 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.44903588 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.44839361 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.44605006 |
| 122 | MP0003045_fibrosis | 0.44074413 |
| 123 | MP0002638_abnormal_pupillary_reflex | 0.43511650 |
| 124 | MP0008260_abnormal_autophagy | 0.43087375 |
| 125 | MP0002873_normal_phenotype | 0.43000353 |
| 126 | MP0002254_reproductive_system_inflammat | 0.42387169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 8.63341066 |
| 2 | Focal motor seizures (HP:0011153) | 7.62082900 |
| 3 | Focal seizures (HP:0007359) | 5.66690154 |
| 4 | Visual hallucinations (HP:0002367) | 4.49169477 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.23598411 |
| 6 | Torticollis (HP:0000473) | 4.11986737 |
| 7 | Poor eye contact (HP:0000817) | 3.93003140 |
| 8 | Action tremor (HP:0002345) | 3.81029560 |
| 9 | Generalized tonic-clonic seizures (HP:0002069) | 3.79809611 |
| 10 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.72461560 |
| 11 | Focal dystonia (HP:0004373) | 3.69329917 |
| 12 | Ankle clonus (HP:0011448) | 3.66107754 |
| 13 | Abnormal social behavior (HP:0012433) | 3.65816991 |
| 14 | Impaired social interactions (HP:0000735) | 3.65816991 |
| 15 | Anxiety (HP:0000739) | 3.59370675 |
| 16 | Absence seizures (HP:0002121) | 3.55984761 |
| 17 | Craniofacial dystonia (HP:0012179) | 3.53631588 |
| 18 | Febrile seizures (HP:0002373) | 3.51248149 |
| 19 | Atonic seizures (HP:0010819) | 3.49798942 |
| 20 | Depression (HP:0000716) | 3.45715918 |
| 21 | Annular pancreas (HP:0001734) | 3.37628600 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.37124221 |
| 23 | Resting tremor (HP:0002322) | 3.32553946 |
| 24 | Dialeptic seizures (HP:0011146) | 3.32099331 |
| 25 | Broad-based gait (HP:0002136) | 3.28096195 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.23017857 |
| 27 | Postural instability (HP:0002172) | 3.22672544 |
| 28 | Cerebral hypomyelination (HP:0006808) | 3.21301706 |
| 29 | Megalencephaly (HP:0001355) | 3.12826911 |
| 30 | Status epilepticus (HP:0002133) | 3.12191490 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 3.09971558 |
| 32 | Abnormality of the lower motor neuron (HP:0002366) | 3.07263464 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 3.05270388 |
| 34 | Dysmetria (HP:0001310) | 3.04937928 |
| 35 | Hyperventilation (HP:0002883) | 3.04869054 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 3.04063506 |
| 37 | Akinesia (HP:0002304) | 3.00552450 |
| 38 | Neurofibrillary tangles (HP:0002185) | 3.00161016 |
| 39 | Urinary urgency (HP:0000012) | 2.92684707 |
| 40 | Papilledema (HP:0001085) | 2.91443482 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.90344774 |
| 42 | Ankyloglossia (HP:0010296) | 2.79685307 |
| 43 | Stereotypic behavior (HP:0000733) | 2.79213006 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.79079867 |
| 45 | Apathy (HP:0000741) | 2.74396279 |
| 46 | Intention tremor (HP:0002080) | 2.73246017 |
| 47 | Scanning speech (HP:0002168) | 2.70133993 |
| 48 | Impaired vibratory sensation (HP:0002495) | 2.69960713 |
| 49 | Dysmetric saccades (HP:0000641) | 2.67342578 |
| 50 | Truncal ataxia (HP:0002078) | 2.63673303 |
| 51 | Bradykinesia (HP:0002067) | 2.61432776 |
| 52 | Spastic gait (HP:0002064) | 2.57846218 |
| 53 | Amblyopia (HP:0000646) | 2.51815646 |
| 54 | Hemiplegia (HP:0002301) | 2.50218987 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.48707857 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.48707857 |
| 57 | Polygenic inheritance (HP:0010982) | 2.48290035 |
| 58 | Mutism (HP:0002300) | 2.46120583 |
| 59 | Impaired smooth pursuit (HP:0007772) | 2.45271365 |
| 60 | Diminished motivation (HP:0000745) | 2.43101757 |
| 61 | Pointed chin (HP:0000307) | 2.37209951 |
| 62 | Hand muscle atrophy (HP:0009130) | 2.37167091 |
| 63 | Lower limb amyotrophy (HP:0007210) | 2.32999819 |
| 64 | Abnormality of the corticospinal tract (HP:0002492) | 2.32466462 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.32309516 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.31952697 |
| 67 | Clonus (HP:0002169) | 2.29401906 |
| 68 | Hemiparesis (HP:0001269) | 2.27781710 |
| 69 | Peripheral hypomyelination (HP:0007182) | 2.27692706 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26251754 |
| 71 | Sleep apnea (HP:0010535) | 2.25950235 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.22070738 |
| 73 | Generalized myoclonic seizures (HP:0002123) | 2.19659965 |
| 74 | Atrioventricular block (HP:0001678) | 2.12367170 |
| 75 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.11721959 |
| 76 | Bronchomalacia (HP:0002780) | 2.10905245 |
| 77 | Lower limb muscle weakness (HP:0007340) | 2.10275276 |
| 78 | Abnormality of the periventricular white matter (HP:0002518) | 2.09082459 |
| 79 | Rapidly progressive (HP:0003678) | 2.08323698 |
| 80 | Choreoathetosis (HP:0001266) | 2.07386536 |
| 81 | Incomplete penetrance (HP:0003829) | 2.07287723 |
| 82 | Abnormal EKG (HP:0003115) | 2.06845571 |
| 83 | Prolonged QT interval (HP:0001657) | 2.06274115 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.05874792 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.05874792 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 2.05874792 |
| 87 | Genetic anticipation (HP:0003743) | 2.05714862 |
| 88 | Drooling (HP:0002307) | 2.05708881 |
| 89 | Excessive salivation (HP:0003781) | 2.05708881 |
| 90 | Tetraplegia (HP:0002445) | 2.04496340 |
| 91 | Bundle branch block (HP:0011710) | 2.03601181 |
| 92 | Heart block (HP:0012722) | 2.01438170 |
| 93 | Rigidity (HP:0002063) | 2.00525787 |
| 94 | Diplopia (HP:0000651) | 1.98079441 |
| 95 | Abnormality of binocular vision (HP:0011514) | 1.98079441 |
| 96 | Delayed CNS myelination (HP:0002188) | 1.97612070 |
| 97 | Progressive inability to walk (HP:0002505) | 1.97585731 |
| 98 | Abnormality of oral frenula (HP:0000190) | 1.95576315 |
| 99 | CNS hypomyelination (HP:0003429) | 1.95490471 |
| 100 | Obstructive sleep apnea (HP:0002870) | 1.94916333 |
| 101 | Spinal canal stenosis (HP:0003416) | 1.94600424 |
| 102 | Lower limb asymmetry (HP:0100559) | 1.94300602 |
| 103 | Dementia (HP:0000726) | 1.93061226 |
| 104 | Neuronal loss in central nervous system (HP:0002529) | 1.90129186 |
| 105 | Insidious onset (HP:0003587) | 1.89984474 |
| 106 | Termporal pattern (HP:0011008) | 1.89984474 |
| 107 | Abnormality of saccadic eye movements (HP:0000570) | 1.88474780 |
| 108 | Limb dystonia (HP:0002451) | 1.87708274 |
| 109 | Insomnia (HP:0100785) | 1.83828255 |
| 110 | Fetal akinesia sequence (HP:0001989) | 1.82636257 |
| 111 | Spastic tetraparesis (HP:0001285) | 1.81918739 |
| 112 | Memory impairment (HP:0002354) | 1.81588953 |
| 113 | Gait ataxia (HP:0002066) | 1.81235753 |
| 114 | Abnormal atrioventricular conduction (HP:0005150) | 1.81128224 |
| 115 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80804989 |
| 116 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80804989 |
| 117 | Delusions (HP:0000746) | 1.78276330 |
| 118 | Distal sensory impairment (HP:0002936) | 1.77924786 |
| 119 | Abnormality of the Achilles tendon (HP:0005109) | 1.77463031 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 1.76704544 |
| 121 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.72304975 |
| 122 | Confusion (HP:0001289) | 1.68379585 |
| 123 | Neonatal onset (HP:0003623) | 1.67983531 |
| 124 | Split foot (HP:0001839) | 1.66950036 |
| 125 | Increased circulating renin level (HP:0000848) | 1.64187416 |
| 126 | Hammertoe (HP:0001765) | 1.63721282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.26996748 |
| 2 | MAP3K9 | 4.09969311 |
| 3 | DAPK2 | 3.61812158 |
| 4 | PRKD3 | 2.92230616 |
| 5 | KSR2 | 2.88961252 |
| 6 | * EPHA4 | 2.83645832 |
| 7 | CAMKK1 | 2.42407580 |
| 8 | MINK1 | 2.41218544 |
| 9 | MAP3K4 | 2.39177336 |
| 10 | RIPK4 | 2.34260967 |
| 11 | PAK6 | 2.23902128 |
| 12 | MARK1 | 2.06092556 |
| 13 | NTRK2 | 2.02857186 |
| 14 | MAP3K13 | 1.96515319 |
| 15 | NTRK1 | 1.93222207 |
| 16 | DAPK1 | 1.91103438 |
| 17 | MAP2K7 | 1.84110595 |
| 18 | ARAF | 1.81623840 |
| 19 | KSR1 | 1.80631169 |
| 20 | TAOK1 | 1.78316800 |
| 21 | CDK5 | 1.69901163 |
| 22 | MAP2K4 | 1.68434996 |
| 23 | MAP3K2 | 1.56786070 |
| 24 | FES | 1.50924390 |
| 25 | TYRO3 | 1.48596178 |
| 26 | TNIK | 1.47564610 |
| 27 | SIK2 | 1.41841387 |
| 28 | STK38 | 1.38216881 |
| 29 | PRPF4B | 1.29478284 |
| 30 | PINK1 | 1.24160063 |
| 31 | CAMKK2 | 1.22795864 |
| 32 | RAF1 | 1.19348609 |
| 33 | LMTK2 | 1.17226607 |
| 34 | PRKCG | 1.14135664 |
| 35 | SGK494 | 1.11266148 |
| 36 | SGK223 | 1.11266148 |
| 37 | MAP3K12 | 1.07488984 |
| 38 | CDK19 | 1.06237910 |
| 39 | PRKCH | 1.04239586 |
| 40 | GRK5 | 1.00307181 |
| 41 | CAMK1 | 0.97966526 |
| 42 | SGK3 | 0.96769556 |
| 43 | SGK2 | 0.96114565 |
| 44 | PLK2 | 0.95829272 |
| 45 | STK11 | 0.94935950 |
| 46 | CDK15 | 0.92456812 |
| 47 | CDK18 | 0.92165834 |
| 48 | MAP3K11 | 0.91915791 |
| 49 | PDPK1 | 0.91094760 |
| 50 | BMPR2 | 0.90754802 |
| 51 | MST1R | 0.90217634 |
| 52 | NEK1 | 0.88626346 |
| 53 | PTK2B | 0.87437009 |
| 54 | RIPK1 | 0.85730055 |
| 55 | PDK1 | 0.85173423 |
| 56 | MAPK13 | 0.85028468 |
| 57 | CAMK2A | 0.84381903 |
| 58 | RET | 0.84294077 |
| 59 | CDK14 | 0.84154864 |
| 60 | MARK2 | 0.84072410 |
| 61 | PHKG1 | 0.84053905 |
| 62 | PHKG2 | 0.84053905 |
| 63 | UHMK1 | 0.83062291 |
| 64 | SGK1 | 0.81316861 |
| 65 | TESK1 | 0.81098632 |
| 66 | MAP3K1 | 0.80374588 |
| 67 | CDK11A | 0.79943240 |
| 68 | LIMK1 | 0.77497034 |
| 69 | ALK | 0.74225267 |
| 70 | TRIB3 | 0.73386416 |
| 71 | CASK | 0.70257926 |
| 72 | DAPK3 | 0.68749893 |
| 73 | TNK2 | 0.68187416 |
| 74 | OXSR1 | 0.66718313 |
| 75 | CAMK2B | 0.66543018 |
| 76 | PRKG2 | 0.65949839 |
| 77 | MAP2K1 | 0.64778193 |
| 78 | PRKCZ | 0.63353415 |
| 79 | LATS2 | 0.61254734 |
| 80 | EPHA2 | 0.60890337 |
| 81 | RPS6KA3 | 0.58161130 |
| 82 | MAP3K7 | 0.57705166 |
| 83 | BRSK1 | 0.55661889 |
| 84 | CAMK4 | 0.54855384 |
| 85 | PAK3 | 0.54164139 |
| 86 | NEK6 | 0.50820415 |
| 87 | FYN | 0.50004092 |
| 88 | PKN1 | 0.49322535 |
| 89 | ICK | 0.48035025 |
| 90 | DYRK1A | 0.46759117 |
| 91 | FGFR2 | 0.46455364 |
| 92 | ROCK2 | 0.46402356 |
| 93 | CAMK2D | 0.44716882 |
| 94 | BRAF | 0.44515290 |
| 95 | CAMK2G | 0.43018259 |
| 96 | CSNK1G2 | 0.42913181 |
| 97 | MAPK10 | 0.42598285 |
| 98 | MAPK12 | 0.42428960 |
| 99 | PRKD2 | 0.42321436 |
| 100 | DMPK | 0.41596112 |
| 101 | PTK2 | 0.41256904 |
| 102 | MAP2K6 | 0.39868778 |
| 103 | MOS | 0.39686655 |
| 104 | DDR2 | 0.39549609 |
| 105 | ERBB2 | 0.39418989 |
| 106 | MET | 0.37620335 |
| 107 | PRKCE | 0.36473851 |
| 108 | CDC42BPA | 0.35589747 |
| 109 | WNK1 | 0.35440095 |
| 110 | BMX | 0.35264166 |
| 111 | PRKCB | 0.34584165 |
| 112 | IRAK2 | 0.34549763 |
| 113 | PRKCA | 0.33813716 |
| 114 | PRKACG | 0.33590167 |
| 115 | SCYL2 | 0.32131928 |
| 116 | CCNB1 | 0.31176860 |
| 117 | CAMK1G | 0.30079486 |
| 118 | MAPK8 | 0.28139164 |
| 119 | ROCK1 | 0.27995804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42873340 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.18028554 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.87380593 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.82387365 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53536273 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.52268684 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.44824047 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43548356 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38312469 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37868566 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.21650992 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.11802765 |
| 13 | Cocaine addiction_Homo sapiens_hsa05030 | 2.05536470 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.03662342 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.01891276 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89718080 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85040337 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.80285948 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78206175 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.76573579 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.64178002 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61823476 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.58780332 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.53527172 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52569563 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45734902 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41032946 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30376654 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.28038071 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26823959 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.26493210 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25484479 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25270160 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.22092508 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20487747 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20439464 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.16828061 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14216077 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.02396019 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02307477 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95021027 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94533447 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92685657 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90237920 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88354235 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88101580 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85799139 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85785353 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.84208015 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83635448 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81495599 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81087056 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79371225 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77666349 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77608040 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76989754 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75635106 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74046237 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69490152 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67705281 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66876838 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66554427 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62958770 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59821292 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.57814199 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57148780 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55531009 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55315092 |
| 69 | * Axon guidance_Homo sapiens_hsa04360 | 0.54916196 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54639893 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.53520485 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53498772 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53042284 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53014418 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52756968 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52674205 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52003089 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51493499 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47941909 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46938864 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46529676 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45064966 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44959838 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.43980579 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43629414 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42717422 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41795061 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41757866 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.41544050 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40012711 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39771333 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39724306 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38361340 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37445833 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37244983 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36150958 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34010130 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33735022 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33590473 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33249973 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33117106 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32852782 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32731219 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31622802 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.30632383 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30398220 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30249562 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29991605 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29648421 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29192330 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29117249 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29007525 |
| 113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28259056 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.26553658 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26293443 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26222727 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24142711 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22013039 |

